0001209191-20-042033.txt : 20200709
0001209191-20-042033.hdr.sgml : 20200709
20200709185137
ACCESSION NUMBER: 0001209191-20-042033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200707
FILED AS OF DATE: 20200709
DATE AS OF CHANGE: 20200709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barth Jay
CENTRAL INDEX KEY: 0001601896
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 201021410
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-07
0
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001601896
Barth Jay
C/O AMICUS THERAPEUTICS, INC.
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
0
1
0
0
Chief Medical Officer
Common Stock
2020-07-07
4
M
0
51531
8.61
A
214735
D
Common Stock
2020-07-07
4
M
0
64601
9.03
A
279336
D
Common Stock
2020-07-07
4
M
0
12804
10.04
A
292140
D
Common Stock
2020-07-07
4
M
0
50052
12.28
A
342192
D
Common Stock
2020-07-07
4
S
0
178988
15.9002
D
163204
D
Common Stock
2020-07-08
4
M
0
16910
8.61
A
180114
D
Common Stock
2020-07-08
4
M
0
16549
9.03
A
196663
D
Common Stock
2020-07-08
4
M
0
8599
10.04
A
205262
D
Common Stock
2020-07-08
4
M
0
22052
12.28
A
227314
D
Common Stock
2020-07-08
4
S
0
64110
15.9191
D
163204
D
Common Stock
20
I
By Daughter
Stock Options (right to buy)
8.61
2020-07-07
4
M
0
51531
0.00
D
2025-01-02
Common Stock
51531
28469
D
Stock Options (right to buy)
9.03
2020-07-07
4
M
0
64601
0.00
D
2026-01-04
Common Stock
64601
25399
D
Stock Options (right to buy)
10.04
2020-07-07
4
M
0
12804
0.00
D
2029-01-02
Common Stock
12804
69840
D
Stock Options (right to buy)
12.28
2020-07-07
4
M
0
50052
0.00
D
2025-06-01
Common Stock
50052
39948
D
Stock Options (right to buy)
8.61
2020-07-08
4
M
0
16910
0.00
D
2025-01-02
Common Stock
16910
11559
D
Stock Options (right to buy)
9.03
2020-07-08
4
M
0
16549
0.00
D
2026-01-04
Common Stock
16549
8850
D
Stock Options (right to buy)
10.04
2020-07-08
4
M
0
8599
0.00
D
2029-01-02
Common Stock
8599
61241
D
Stock Options (right to buy)
12.28
2020-07-08
4
M
0
22052
0.00
D
2025-06-01
Common Stock
22052
17896
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.90 to $15.91. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $15.90 to $16.12 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
All of the options were fully vested and exercisable as of the transaction date.
As of July 7, 2020, 30,987 options were fully vested and exercisable and 51,657 remained unvested from this grant.
As of July 8, 2020, 18,183 options were fully vested and exercisable and 51,657 remained unvested from this grant.
/s/ Christian Formica, Attorney-in-Fact
2020-07-09